More than 75% of the patients in whom deep vein thrombosis (DVT) 3 is suspected and who are referred for objective testing-commonly performed with legcompression ultrasonography-do not have DVT (1, 2 ) . D-dimer testing for DVT has been introduced to improve the diagnostic process and, in particular, to reduce the number of unnecessary referrals for leg-compression ultrasonography. Concentrations of D-dimer are increased in patients with DVT, but may also be increased in other conditions such as cancer, infections, pregnancy, and recent surgery. Hence, D-dimer tests are typically used as rule-out tests (3, 4 ) . Although D-dimer testing is readily available to many hospital physicians within their central laboratories, this is often not the case for primary care physicians. Most patients with suspected DVT, however, are first seen in primary care settings, and for such cases referral to central laboratories for D-dimer testing is not always a practical solution. Therefore, to enable exclusion of DVT in the doctor's office, several point-of-care D-dimer tests have been developed (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . These tests yield results within 10 -15 min and in many cases may eliminate the need for referrals to central laboratories or diagnostic services. Indeed, a recent study demonstrated that the use of a qualitative point-of-care D-dimer test was both safe and cost-effective in primary care (15, 16 ) . Consequently, the introduction of point-of-care D-dimer tests for use in primary care settings is eagerly awaited.
As with all new therapies, however, diagnostic devices, including biomarker tests, must undergo rigorous and phased evaluation before they are introduced in daily practice. Well-tested, conventional, laboratory-based D-dimer assays can be safely substituted with point-of-care tests only if the new tests show high negative predictive value and sensitivity. As with any D-dimer test, point-of-care tests will be used only in combination with a clinical assessment (e.g., with a validated clinical-decision rule), and their added value beyond such clinical assessment must be evaluated. As a first step in the evaluation of novel diagnostic techniques, a single-test approach is advocated in which the results of the new test are compared with the current reference standard (17) (18) (19) (20) .
In the present study of 4 quantitative point-of-care D-dimer tests and 1 qualitative point-of-care D-dimer test, we aimed to quantify and compare the diagnostic accuracy of these tests by direct comparison with legcompression ultrasonography as a reference method in primary care patients with suspected DVT. Furthermore, the user-friendliness of each assay was assessed to provide information to assist physicians in choosing a point-of-care test, particularly when multiple pointof-care tests show similar diagnostic accuracy.
Material and Methods

PATIENTS
We prospectively identified 577 consecutive primary care patients with suspected DVT in 3 regions of the Netherlands (inclusion period November 2006 to September 2008). Suspicion of DVT was based on pain, swelling, or redness of the leg. Patients were excluded from the study if they were younger than 18 years; undergoing treatment with anticoagulant therapy with vitamin K antagonists or low molecular weight heparin, or were unable or unwilling to give informed consent. All study participants were subsequently referred by their general practitioner for compression ultrasonography, which was performed at 3 participating primary care diagnostic centers (Deventer Hospital, STAR Medical Diagnostic Centre Rotterdam, and Medical Diagnostic Centre LabNoord Groningen). The study protocol was approved by the medical ethics committees of the participating centers.
BLOOD COLLECTION
In all patients, venous whole blood was drawn from the anterior cubital vein. Depending on the assay, venous blood was collected into tubes containing 105 mmol/L citrate, K 2 EDTA (1.8 g/L whole blood), or lithium heparin (15 000 USP units/L whole blood). Immediately after venous blood collection, capillary blood was collected via a finger prick.
POINT-OF-CARE D-DIMER TESTS (INDEX TESTS)
The 5 point-of-care D-dimer tests were performed on each patient's blood sample, according to the manufacturer's instructions. Each test was performed by laboratory workers unfamiliar with point-of-care testing. Hence, all laboratory workers received brief instructions on how to perform the respective point-of-care tests. Laboratory workers were unaware of the result of the compression ultrasonography, and blinded for the outcome of the other D-dimer tests.
QUANTITATIVE D-DIMER TESTS
D-dimer measurements were based on assay-specific reference curves. The quantitative test results were reported either as D-dimer units (D-DU), which were based on calibration with purified fibrin fragment D-dimer, or as fibrinogen equivalent units (FEU), which were based on the amount of purified fibrinogen used for the preparation of a cross-linked fibrin clot, which was then degraded by plasmin and used as calibrator. A test outcome given in FEU can be converted to D-DU by using a conversion factor of 1.8 (21 ) . Consequently, 1 g/L FEU corresponds with 1.8 g/L D-DU. All D-dimer measurement units were converted into FEU (g/L). We included 4 quantitative assays in our study. 
REFERENCE STANDARD (COMPRESSION ULTRASONOGRAPHY)
After venous and capillary blood was drawn, each patient underwent real-time compression ultrasonography of the symptomatic leg. DVT was considered present if 1 of the proximal veins including the popliteal vein was not fully compressible. The physician who judged the result of the compression ultrasonography was blinded to the outcome of the D-dimer assays. Compression ultrasonography was repeated within 1 week in patients whose ultrasound results showed no evidence of DVT.
USER-FRIENDLINESS OF THE POINT-OF-CARE D-DIMER TESTS
To evaluate the user-friendliness of the 5 point-of-care D-dimer tests, 20 nurses from a thrombosis service, who were unfamiliar with laboratory testing, received in-depth instruction by the manufacturers on the use of the assays. Subsequently they practiced each test twice to gain familiarity with the measurements. Directly after performing each test, in a random order, for the third time, the nurses completed in a questionnaire concerning the user-friendliness of the 5 tests.
DATA ANALYSIS
Estimates of diagnostic accuracy for the point-of-care D-dimer tests, including sensitivity, specificity, negative likelihood ratio, and negative predictive value (with their corresponding 95% CIs) were calculated at the manufacturers' provided thresholds. In addition, the area under the ROC curve (AUC or c-statistic) was determined for each quantitative point-of-care D-dimer test as a measure of discriminative ability in distinguishing between patients with and without
DVT. An AUC of 0.5 reflects no discriminating ability, whereas a perfect diagnostic tool has an AUC of 1.0 (22 ) . Missing data rates for study variables ranged from 0% for results of the compression ultrasonography (used to establish DVT prevalence) to 11.4% for presence of vein distension. Because missing data seldom occur randomly, it is widely acknowledged that excluding the data obtained from study participants who have a missing value leads not only to a loss of statistical power but also to biased results. To decrease bias and increase statistical efficiency, it is better to impute missing values rather than perform a complete case analysis (23) (24) (25) (26) . Accordingly, before conducting the above analysis, we imputed our missing data using multiple regression imputation techniques available in R2.8 software (R foundation for Statistical Computing, www.R-project.org).
Results
The study included 577 primary care patients with suspected DVT. In 71 patients (12.3%) compression ultrasonography showed a proximal DVT. The mean age of the study population was 58 years, and 63% of participants were women. Additional patient characteristics are presented in Table 1 .
ACCURACY MEASURES
All accuracy measures of the point-of-care D-dimer tests are presented in Table 2 . At the thresholds provided by the manufacturers, all point-of-care D-dimer tests showed negative predictive values higher than 98%. Sensitivities of the Vidas, Pathfast, Triage, Cardiac, and Clearview Simplify D-dimer tests were 0.99, 0.98, 0.97, 0.94, and 0.91, respectively, with corre- 
USER-FRIENDLINESS
The ease of operation of the D-dimer tests and the risk of errors in the procedure were comparable among the 4 quantitative point-of-care D-dimer tests ( The initial presentation of DVT often occurs in the primary care setting, where the accessibility of additional testing (conventional D-dimer or compression ultrasonography) is relatively poor compared to a hospital setting. Availability of sensitive point-of-care D-dimer tests is therefore highly valuable in the primary care setting. However, to the best of our knowledge, this study was the first to explore the diagnostic accuracy of different point-of-care D-dimer tests for DVT in primary care patients. The results of this study can therefore be compared only to studies performed in the hospital setting. The differences found may be difficult to interpret because they may be attributable to spectrum bias (i.e., diagnostic accuracy of a test may differ in different subgroups of patients or domain) and variation in DVT prevalence (27 ) . However, the results of this study are largely in accordance with other studies in the hospital setting performed to evaluate the accuracy of a point-of-care D-dimer test for the exclusion of DVT. We recently performed a diagnostic metaanalysis on 4 currently available point-of-care D-dimer tests (8 ) . In this metaanalysis the pooled sensitivity for the Clearview Simplify was 0.87 vs 0.91 in this study; for the Cardiac 0.96 vs 0.94, and for the Triage point-of-care D-dimer 0.93 vs 0.97 with corresponding pooled specificities of 0.62 vs 0.64, 0.57 vs 0.62, and 0.48 vs 0.48. Hence, our study showed slightly lower sensitivity for the Cardiac and slightly higher sensitivity for the Triage point-of-care D-dimer test. Although few studies have been performed for these new point-of-care assays, our results still fall within the (relatively wide) 95% CIs of the pooled analysis of the metaanalysis. In particular, more studies are needed of the quantitative assays in the domain of primary care. A previous study of the diagnostic accuracy of the Pathfast assay showed a higher sensitivity (1.0 vs 0.98) and much higher specificity (0.63 vs 0.39) compared to our study (7 ) . Many studies have evaluated the diagnostic accuracy of the Vidas D-dimer test, which showed, as did our study, high sensitivity and only moderate specificity for excluding DVT (4 ) .
Because all point-of-care D-dimer tests seemed to show good diagnostic accuracy to aid in the exclusion of DVT, the decision of which test to use will likely depend on their user-friendliness. For example, the user-friendliness of the Vidas and Pathfast tests may be limited for primary care owing to the size of the devices and because of the need for a relatively difficult and time-consuming calibration and analyzer warm-up time. In addition, the Vidas test has to be performed with citrated plasma. On the basis of user-friendliness the Cardiac and Triage devices may be preferred for use in an emergency department setting or small primary care clinics. In addition, these tests produce a D-dimer test result within 15 min and can provide measurements of other (cardiovascular) biomarkers, such as brain natriuretic peptide, troponin, and C-reactive protein. The Clearview Simplify test is also userfriendly for primary care, because it is easily portable, requires no analyzer, can be performed on capillary whole blood, and requires no calibration.
LIMITATIONS
For our results to be fully understood, we must discuss a few issues. In this study all point-of-care testing was performed by laboratory workers. Sometimes pointof-care equipment may seem to be easy to use and robust in the hands of laboratory staff, but it may cause significant problems for nonlaboratory users within their own environment (28 ) . For example, problems with the reproducibility of the technique may arise when it is used only infrequently by an isolated general practitioner. The laboratory workers in our study were unfamiliar with point-of-care testing and therefore received instruction from the manufacturers on how to use the point-of-care devices. We also sought opinions on the user-friendliness of the point-of-care D-dimer tests from nurses without laboratory experience who learned to perform the tests. More than 90% of these nurses judged the quantitative assays as easy to use. Given that posttraining surveillance is assured, we therefore believe that it is feasible for point-of-care testing to be performed in primary care settings by either trained nurses or general practitioners.
Another issue is that a multivariable approach may be preferable to quantify the added value of a new diagnostic test beyond existing test results (17) (18) (19) (20) . Accordingly, a D-dimer test cannot be used as a stand-alone test (4 ) but is typically combined with other patient information such as sex, calf swelling, and vein distension, commonly summarized in a formal clinical decision rule. Our study clearly did not use such a multivariable approach. Point-of-care D-dimer tests have only recently been introduced and-as an initial step-we first aimed to compare the diagnostic performance of these tests by themselves. For the quantitative Pathfast, Cardiac, and Triage point-of-care D-dimer tests our study is the largest to date, and for the qualitative Clearview Simplify only 1 previous study in the domain of primary care has been performed, for which patient management was guided by a clinical decision rule and the result of the D-dimer test (15 ) . This study demonstrated that the use by general practitioners of the Clearview Simplify D-dimer testcombined with a clinical decision rule-prevented almost 50% of referrals and missed only 1.4% of DVT cases during follow-up. Hence, point-of-care D-dimer testing safely prevented unnecessary referral of patients for additional testing. Not surprisingly, the use of point-of-care D-dimer testing also was found to improve the costeffectiveness of health care use (16 ) . In the current study, quantitative point-of-care D-dimer tests showed even higher sensitivity and negative predictive value to rule out DVT compared with the qualitative Clearview Simplify. This higher sensitivity and negative predictive value, however, comes at the cost of slightly lower specificity of these quantitative tests, and accordingly may result in more false-positive tests (i.e., referrals for ultrasonography). Therefore more studies are needed to assess the true or added value of point-of-care tests (particularly quantitative tests) to pretest information that is commonly applicable in these patients. Nevertheless, the present results are promising for the use of point-of-care D-dimer tests to exclude DVT in the primary care setting. To provide additional insight into the possible results of such future management studies based on the existing data, we plotted a Fagan nomogram. In such a nomogram, the posttest probabilities (i.e., probability of missing DVT) are calculated using the accuracy measure (i.e., negative likelihood ratio) of the point-of-care D-dimer test, depending on a chosen pretest probability. If, for example, a patient has a pretest probability of only 5% with the use of 1 of the available diagnostic prediction rules for DVT (2, 15 ) , a negative Cardiac D-dimer result yields a posttest probability of (only) 0.5%. A Fagan nomogram is presented in Fig. 1 for 2 different point-of-care D-dimer tests (Cardiac and Vidas D-dimer). Different posttest probabilities can be calculated for different pretest probabilities by drawing a line from these pretest probabilities and the likelihood ratio.
A third consideration is that we used compression ultrasonography as the reference standard for deep venous thrombosis. In a metaanalysis, Goodacre and col-leagues found a pooled sensitivity of compression ultrasonography for detection of proximal DVT of 0.94, compared with venography as reference standard (29 ) . This finding implies that even compression ultrasonography might miss a small proportion of DVT cases. Moreover, we do not have follow-up data for our patients. Hence, some DVT cases may have been missed, which may have led to a small overestimation of the sensitivity of the point-of-care D-dimer tests. However, as with many reference standards, compression ultrasonography is not perfect, but is now the accepted reference standard in daily clinical practice. For our study compression ultrasonograms were repeated if the initial result was negative. This resulted in only 3 extra cases of DVT. So we believe that the possible overestimation of the sensitivity could not have been very large.
Conclusions
In a direct assay comparison, all point-of-care D-dimer tests showed similar high sensitivities. Specificities varied and were highest for the Cardiac and Clearview Simplify. Although future diagnostic studies are needed in the primary care setting to evaluate patient management in daily practice guided by both a clinical Solid lines are for 5% and dashed lines for 30% pretest probability. Accordingly, the posttest probabilities were 0.2% and 1.3% for the Vidas D-dimer and 0.5% and 4.1% for the Cardiac D-dimer. For other pretest probabilities, the posttest probability can be calculated by simply drawing a line through the negative likelihood ratio of the respective point-of-care D-dimer test and the chosen pretest probability.
decision rule and a point-of-care D-dimer test, our results indicate that point-of-care D-dimer tests have good diagnostic accuracy to aid in safe and costeffective exclusion of DVT in the doctor's office. Because the quantitative Cardiac and Triage and the qualitative Clearview Simplify were rated the most user-friendly for primary care, these tests may be the preferred tests in such future management studies.
